Citations

Clear

3314 citation(s) found for "Yu, Alexander".

Stem cells, cell therapies, and bioengineering in lung biology and diseases 2023
Hynds, Robert E. , Magin, Chelsea M. , Ikonomou, Laertis , Aschner, Yael , Beers, Michael F. , Burgess, Janette K. , Heise, Rebecca L. , Hume, Patrick S. , Krasnodembskaya, Anna , Mei, Shirley H. J. , Park, Jin‐Ah , Reynolds, Susan D. , Tschumperlin, Daniel J. , Tanneberger, Alicia E. , Waters, Christopher M. , Zettler, Patricia J. , Weiss, Daniel J. , Ryan, Amy L. , Krasnodembskaya, Anna D , Park, Jin-Ah , Tschumperlin, Daniel J , Waters, Christopher M , Ryan, Amy L , Burgess, Janette K , Misharin, Alexander V. , Vaidyanathan, Sriram

Mayo Clinic

American Journal of Physiology-Lung Cellular and Molecular Physiology | May 21, 2024 | Volume: 327 | Issue: 3 | Pages: L327-L340

10.1152/ajplung.00052.2024 | PMID 38772903 Get It

Repair and regeneration of a diseased lung using stem cells or bioengineered tissues is an exciting therapeutic approach for a variety of lung diseases and critical illnesses. Over the past decade, increasing evidence from preclinical models suggests that mesenchymal stromal cells, which are not normally resident in the lung, can be used to modulate immune responses after injury, but there have been challenges in translating these promising findings to the clinic. In parallel, there has been a surge in bioengineering studies investigating the use of artificial and acellular lung matrices as scaffolds for three-dimensional lung or airway regeneration, with some recent attempts of transplantation in large animal models. The combination of these studies with those involving stem cells, induced pluripotent stem cell derivatives, and/or cell therapies is a promising and rapidly developing research area. These studies have been further paralleled by significant increases in our understanding of the molecular and cellular events by which endogenous lung stem and/or progenitor cells arise during lung development and participate in normal and pathological remodeling after lung injury. For the 2023 Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Diseases Conference, scientific symposia were chosen to reflect the most cutting-edge advances in these fields. Sessions focused on the integration of “omics” technologies with function, the influence of immune cells on regeneration, and the role of the extracellular matrix in regeneration. The necessity for basic science studies to enhance fundamental understanding of lung regeneration and to design innovative translational studies was reinforced throughout the conference.
Patient Outcomes Compared Between Admissions Coordinated by the Transfer Center and Emergency Department at a U.S. Tertiary Care Hospital
Ryu, Alexander J. , Parikh, Riddhi S. , Newman, James S. , Burton, Melanie , Pagali, Sandeep R. , Burton, M. Caroline , Ryu, Alexander J. , Fischer, Karen M. , Burton, M. Caroline

Mayo Clinic

Journal of Patient Safety | May 21, 2024 | Volume: 20 | Issue: 5 | Pages: 352-357

10.1097/pts.0000000000001232 | PMID 38771223 Get It

Background Patient admissions at a U.S. tertiary care hospital occur via the emergency department (ED), or transfer center. We aim to compare the clinical outcomes of patients admitted from the ED to admissions coordinated by the transfer center. Methods Admissions to Mayo Clinic Hospital, Rochester, MN, between July 2019 to June 2021 were identified in this retrospective study and categorized into two cohorts—transfer center and ED. The two cohorts were then matched for age, sex, admitting service, and Charlson Comorbidity Index. Univariate and multivariate analyses were performed to compare hospital length of stay (LOS), mortality, 30-day mortality, and 30-day readmissions between the two cohorts. Results 73,685 admissions were identified, of which 24,262 (33%) were transfer center admissions. In the matched cohorts (n = 19,093, each), in-hospital mortality (2.4% versus 1.9%), 30-day mortality (5.4% versus 3.9%), 30-day readmission (12.7% versus 7.2%), and LOS (6.4 days versus 5.1 days) were significantly higher (P < 0.001) among the admissions coordinated by transfer center. A higher palliative care consultation rate (9.4% versus 6.2%, P < 0.001), and a lower proportion of home discharges home (76.2% versus 82.5%, P < 0.001) among transfer center admissions was observed. Similar findings were noted in multivariate analysis, even when adjusting for LOS. Conclusions Transfer center admissions had higher in-hospital mortality, LOS, 30-day mortality, and 30-day readmission compared to ED admissions. This study also highlights new considerations for palliative care consultation before transfer acceptance, especially to avoid futile transfers. Additional studies analyzing factors behind the outcomes of transfer center admissions are required.
Multi-institutional Protocol Guidance for Pediatric Photon-counting CT
Horst, Kelly K. , Cao, Joseph , McCollough, Cynthia H. , El-Ali, Alex M., Siegel, Marilyn J. , Ramírez-Giraldo, Juan Carlos , O’Donnell, Tom, Bach, Steve, Yu, Lifeng , Cao, Joseph Y , El-Ali, Alex , Frush, Donald P , Siegel, Marilyn J , Ramirez-Giraldo, Juan Carlos , O'Donnell, Tom , Bache, Steve , Yu, Lifeng , McCollough, Cynthia H , Horst, Kelly , El‐Ali, Alexander M.

Mayo Clinic

Radiology | May 21, 2024 | Volume: 311 | Issue: 2 | Pages: No page available

10.1148/radiol.231741 | PMID 38771176 Get It

This article addresses clinical challenges of photon-counting detector (PCD) CT in pediatric patients by outlining fundamental terminology, explaining technical aspects, and providing protocol guidance for the first commercially available PCD CT scanner.
Evaluation of Platelet-rich Plasma and Microneedling for Facial Skin Rejuvenation
Zawawi, Suha, Hochwald, Alexander , Arthurs, Jennifer R. , Tolaymat, Leila , Bruce, Alison J., Pincelli, Thais P, Hochwald, Alexander P, Arthurs, Jennifer, Bruce, Alison, Pincelli, Thaís , Shapiro, Shane A. , Heckman, Michael G.

Mayo Clinic

Plastic and Reconstructive Surgery - Global Open | May 20, 2024 | Volume: 12 | Issue: 5 | Pages: e5829

10.1097/gox.0000000000005829 | PMID 38798929 Get It

Background: The regenerative properties of platelet growth factors make platelet-rich-plasma (PRP) an attractive modality for treatment of aging skin. The main objective of this study was to determine efficacy and safety of PRP injections and microneedling compared with saline injections in women with aging skin of the face. Methods: In this prospective, randomized clinical trial, 18 women with facial aging were randomized to receive either PRP injections to the unilateral face and saline injections to the contralateral side, or vice versa. Microneedling was performed after injections on the entire face. Physician assessment, photographs, and treatment satisfaction questionnaires were used for outcome assessment at baseline and 16- and 24-week follow-ups. Results: There was no evidence of improvement and suggestion of worsening in skin laxity and rhytides from baseline to weeks 4, 16, and 24 for PRP and saline (all P ≤ 0.004) and no notable difference in skin roughness between baseline and follow-up time points for PRP or saline (all P ≥ 0.19). The degree of change in skin laxity, rhytides, and skin roughness from baseline to follow-up time points was similar for PRP and saline. All patients experienced some degree of pain/discomfort and burning/stinging sensation at treatment weeks 4, 8, and 12 for both saline and PRP. Conclusions: PRP injections did not seem to be effective for treatment of aging skin of the face in women, with no notable macroscopic improvement in appearance when compared with baseline or saline injections. Advanced age of study participants (>45 years) and less-sensitive methods of evaluation may be potential contributing factors to the lack of detected response.
Distinct immunometabolic signatures in circulating immune cells define disease outcome in acute-on-chronic liver failure
Feio‐Azevedo, Rita , Boesch, Markus , Radenkovic, Silvia , Melkebeke, Lukas Van , Smets, Lena , Wallays, Marie , Philips, Gino, Oliveira, Janaíne Prata de , Ghorbani, Mohammad , Laleman, Wim , Meersseman, Philippe , Wilmer, Alexander , Cassiman, David , Malenstein, Hannah van , Sánchez, Cristina, Aguilar, Ferrán , Nevens, Frederik , Verbeek, Jef , Denadai‐Souza, Alexandre , Lambrechts, Diether , Korf, Hannelie , Merwe, Van der , Lambrechts, Diether , Lambrechts, Diether , Lambrechts, Diether , Verbeek, Jef , Boeckx, Bram , Triantafyllou, Evangelos , Moreau, Richard , Arroyo, Vicente , Clària, Joan , Ghesquière, Bart

Mayo Clinic

Hepatology | May 18, 2024 | Volume: 81 | Issue: 2 | Pages: 509-522

10.1097/hep.0000000000000907 | PMID 38761406 Get It

Background and Aims: Acute-on-chronic liver failure (ACLF) is a complication of cirrhosis characterized by multiple organ failure and high short-term mortality. The pathophysiology of ACLF involves elevated systemic inflammation leading to organ failure, along with immune dysfunction that heightens susceptibility to bacterial infections. However, it is unclear how these aspects are associated with recovery and nonrecovery in ACLF. Approach and Results: Here, we mapped the single-cell transcriptome of circulating immune cells from patients with ACLF and acute decompensated (AD) cirrhosis and healthy individuals. We further interrogate how these findings, as well as immunometabolic and functional profiles, associate with ACLF-recovery (ACLF-R) or nonrecovery (ACLF-NR). Our analysis unveiled 2 distinct states of classical monocytes (cMons). Hereto, ACLF-R cMons were characterized by transcripts associated with immune and stress tolerance, including anti-inflammatory genes such as RETN and LGALS1. Additional metabolomic and functional validation experiments implicated an elevated oxidative phosphorylation metabolic program as well as an impaired ACLF-R cMon functionality. Interestingly, we observed a common stress-induced tolerant state, oxidative phosphorylation program, and blunted activation among lymphoid populations in patients with ACLF-R. Conversely, ACLF-NR cMon featured elevated expression of inflammatory and stress response genes such as VIM, LGALS2, and TREM1, along with blunted metabolic activity and increased functionality. Conclusions: This study identifies distinct immunometabolic cellular states that contribute to disease outcomes in patients with ACLF. Our findings provide valuable insights into the pathogenesis of ACLF, shedding light on factors driving either recovery or nonrecovery phenotypes, which may be harnessed as potential therapeutic targets in the future.
Development and Validation of a Multilayer Segmentation Model to Quantify Chronic Changes on Kidney Biopsy
Stetzik, Lucas, Alexander, Mariam P., Janowczyk, Andrew , Asghar, Muhammad Sohaib , Jagtap, Jaidip , Barisoni, Laura , Salem, Fadi E , Smith, Maxwell L. , Mullan, Aidan F. , Đenić, Aleksandar , Rule, Andrew D.

Mayo Clinic

Journal of the American Society of Nephrology | May 17, 2024 | Volume: 34 | Issue: 11S | Pages: 313-313

10.1681/asn.20233411s1313c Get It

Prevalence and Outcomes of Anti-Glomerular Basement Membrane Disease with and Without Secondary Glomerular Pathologies
Alexander, Mariam P., Zand, Ladan , Klomjit, Nattawat

Mayo Clinic

Journal of the American Society of Nephrology | May 17, 2024 | Volume: 34 | Issue: 11S | Pages: 262-262

10.1681/asn.20233411s1262a Get It

Identifying the Etiology of Thrombotic Microangiopathy (TMA) Diagnosed by Kidney Biopsy Using Machine Learning Tools (Unsupervised Clustering)
Moubarak, Simon , Alexander, Mariam P., Zand, Jaleh , Ters, Mireille El , Zand, Ladan

Mayo Clinic

Journal of the American Society of Nephrology | May 17, 2024 | Volume: 33 | Issue: 11S | Pages: 197-197

10.1681/asn.20223311s1197a Get It

Clinical Characteristics and Outcomes of Membranous Nephropathy Post Stem Cell Transplant
Zand, Ladan , Alexander, Mariam P., Klomjit, Nattawat , Leung, Nelson

Mayo Clinic

Journal of the American Society of Nephrology | May 17, 2024 | Volume: 33 | Issue: 11S | Pages: 637-637

10.1681/asn.20223311s1637c Get It

Development of a Tissue-Based Classifier of Allograft Inflammation Using Imaging Mass Cytometry
Alexander, Mariam P., Zaidi, Mark , Taner, Timuçin , Stegall, Mark D. , Bentall, Andrew , McKee, Trevor D.

Mayo Clinic

Journal of the American Society of Nephrology | May 17, 2024 | Volume: 33 | Issue: 11S | Pages: 539-539

10.1681/asn.20223311s1539b Get It